Genmab
Iris Pennings currently works at Genmab in Portfolio Analytics and Project Management as of August 2023. Prior experience includes serving as Project Manager for the Biofabrication Facility at the Innovation Center for Advanced Therapies (ICAT) from April 2022 to September 2023, where efforts focused on translating innovative research into therapeutic applications. Previously, Pennings held a postdoctoral position at Universiteit Utrecht, conducting research on osteoarthritis and biofabrication techniques. Additional roles include educational responsibilities and a PhD project in Regenerative Medicine at UMC Utrecht, as well as various internships related to tissue engineering and stem cell research. Pennings holds a Bachelor of Science and a Master's degree from Utrecht University.
This person is not in any teams
This person is not in any offices
Genmab
40 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.